No Data
Piper Sandler Keeps Their Buy Rating on Aligos Therapeutics (ALGS)
Are Medical Stocks Lagging Aligos Therapeutics (ALGS) This Year?
Express News | Aligos Therapeutics- on Sept 3 Got Notice From Nasdaq That Co Regained Compliance With Minimum Bid Price Requirement for Continued Listing
How Much Upside Is Left in Aligos Therapeutics (ALGS)? Wall Street Analysts Think 648.14%
H.C. Wainwright Initiates Aligos Therapeutics(ALGS.US) With Buy Rating, Announces Target Price $75
H.C. Wainwright analyst Ed Arce initiates coverage on $Aligos Therapeutics(ALGS.US)$ with a buy rating, and sets the target price at $75.According to TipRanks data, the analyst has a success rate of 4
Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS)